HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $86.49 billion. The enterprise value is $129.40 billion.
| Market Cap | 86.49B |
| Enterprise Value | 129.40B |
Important Dates
The next estimated earnings date is Friday, April 25, 2025, before market open.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | Mar 17, 2025 |
Share Statistics
HCA Healthcare has 246.20 million shares outstanding. The number of shares has decreased by -5.28% in one year.
| Current Share Class | 246.20M |
| Shares Outstanding | 246.20M |
| Shares Change (YoY) | -5.28% |
| Shares Change (QoQ) | -1.77% |
| Owned by Insiders (%) | 1.34% |
| Owned by Institutions (%) | 66.20% |
| Float | 173.76M |
Valuation Ratios
The trailing PE ratio is 15.96 and the forward PE ratio is 14.10. HCA Healthcare's PEG ratio is 1.14.
| PE Ratio | 15.96 |
| Forward PE | 14.10 |
| PS Ratio | 1.27 |
| Forward PS | 1.15 |
| PB Ratio | 155.29 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.28 |
| P/OCF Ratio | 8.20 |
| PEG Ratio | 1.14 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.34, with an EV/FCF ratio of 22.95.
| EV / Earnings | 22.47 |
| EV / Sales | 1.83 |
| EV / EBITDA | 9.34 |
| EV / EBIT | 12.27 |
| EV / FCF | 22.95 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 81.51.
| Current Ratio | 1.08 |
| Quick Ratio | 0.84 |
| Debt / Equity | 81.51 |
| Debt / EBITDA | 3.03 |
| Debt / FCF | 8.02 |
| Interest Coverage | 5.12 |
Financial Efficiency
Return on equity (ROE) is 824.40% and return on invested capital (ROIC) is 14.86%.
| Return on Equity (ROE) | 824.40% |
| Return on Assets (ROA) | 11.39% |
| Return on Invested Capital (ROIC) | 14.86% |
| Return on Capital Employed (ROCE) | 23.79% |
| Revenue Per Employee | $223,427 |
| Profits Per Employee | $18,228 |
| Employee Count | 316,000 |
| Asset Turnover | 1.22 |
| Inventory Turnover | 22.31 |
Taxes
In the past 12 months, HCA Healthcare has paid $1.87 billion in taxes.
| Income Tax | 1.87B |
| Effective Tax Rate | 21.89% |
Stock Price Statistics
The stock price has increased by +6.80% in the last 52 weeks. The beta is 1.49, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | +6.80% |
| 50-Day Moving Average | 327.00 |
| 200-Day Moving Average | 345.90 |
| Relative Strength Index (RSI) | 67.65 |
| Average Volume (20 Days) | 1,494,804 |
Short Selling Information
The latest short interest is 4.94 million, so 2.01% of the outstanding shares have been sold short.
| Short Interest | 4.94M |
| Short Previous Month | 6.04M |
| Short % of Shares Out | 2.01% |
| Short % of Float | 2.84% |
| Short Ratio (days to cover) | 2.83 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $70.60 billion and earned $5.76 billion in profits. Earnings per share was $22.00.
| Revenue | 70.60B |
| Gross Profit | 28.68B |
| Operating Income | 10.55B |
| Pretax Income | 7.57B |
| Net Income | 5.76B |
| EBITDA | 13.86B |
| EBIT | 10.55B |
| Earnings Per Share (EPS) | $22.00 |
Balance Sheet
The company has $2.02 billion in cash and $45.24 billion in debt, giving a net cash position of -$43.22 billion or -$175.53 per share.
| Cash & Cash Equivalents | 2.02B |
| Total Debt | 45.24B |
| Net Cash | -43.22B |
| Net Cash Per Share | -$175.53 |
| Equity (Book Value) | 555.00M |
| Book Value Per Share | -10.00 |
| Working Capital | 1.24B |
Cash Flow
In the last 12 months, operating cash flow was $10.51 billion and capital expenditures -$4.88 billion, giving a free cash flow of $5.64 billion.
| Operating Cash Flow | 10.51B |
| Capital Expenditures | -4.88B |
| Free Cash Flow | 5.64B |
| FCF Per Share | $22.90 |
Margins
Gross margin is 40.62%, with operating and profit margins of 14.94% and 8.16%.
| Gross Margin | 40.62% |
| Operating Margin | 14.94% |
| Pretax Margin | 12.07% |
| Profit Margin | 8.16% |
| EBITDA Margin | 19.63% |
| EBIT Margin | 14.94% |
| FCF Margin | 7.99% |
Dividends & Yields
This stock pays an annual dividend of $2.88, which amounts to a dividend yield of 0.82%.
| Dividend Per Share | $2.88 |
| Dividend Yield | 0.82% |
| Dividend Growth (YoY) | 9.76% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 13.09% |
| Buyback Yield | 5.28% |
| Shareholder Yield | 6.11% |
| Earnings Yield | 6.68% |
| FCF Yield | 6.54% |
Analyst Forecast
The average price target for HCA Healthcare is $380.20, which is 8.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $380.20 |
| Price Target Difference | 8.23% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 5.97% |
| EPS Growth Forecast (5Y) | 12.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.64 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.64 |
| Piotroski F-Score | 6 |